Andrew Penn — SPARQNOW

At-a-Glance

Clinical Professor at the University of California-San Francisco School of Nursing, teaching psychopharmacology.
Study therapist in the MAPS sponsored Phase 3 study of MDMA-assisted psychotherapy for PTSD, published in Nature Medicine.
Co-PI in the Phase 2 Usona sponsored study of psilocybin facilitated therapy for major depression, published in JAMA.
Co-founder of OPENurses, a professional organization for nurses interested in psychedelic research and practice.
Author on the textbook 'Deliberate Practice in Psychedelic Assisted Therapy', published by American Psychological Association Press.
Holds a Certificate in Psychedelic Therapies and Research and an MS in Nurse Practitioner from the University of California, San Francisco.
Serves as a Steering Committee Member for Psych Congress and Co-chair for Sana Symposium, a national CME meeting.

Biography

Andrew Penn is a board-certified psychiatric nurse practitioner and a Clinical Professor at the University of California-San Francisco School of Nursing, where he teaches psychopharmacology. He received extensive training in Psychedelic Assisted Psychotherapy from the California Institute for Integral Studies, MAPS, and the Usona Institute.